Detected ·
HighLife
$90M—
HighLife, a medtech company developing transcatheter mitral valve replacement (TMVR) technology, has raised $90M in financing co-led by Supernova Invest, Sofinnova Partners, Andera Partners, Merieux Equity Partners, USVP, and other investors to support U.S. pivotal clinical study and European commercial expansion.
- Website
- www.highlifemedical.com
- Amount
- $90 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-22 12:13:41 UTC
- Signal ID
- fb3e8190-494a-45eb-9751-c1f3840bc555
As the API returns it
{
"id": "fb3e8190-494a-45eb-9751-c1f3840bc555",
"created_at": "2026-09-22T12:13:41.515785Z",
"company_name": "HighLife",
"company_website_url": "www.highlifemedical.com",
"company_linkedin_url": "https://www.linkedin.com/company/highlifemedical",
"event_type": "funding",
"funding_amount": 90000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*HighLife, a medtech company developing transcatheter mitral valve replacement (TMVR) technology, has raised $90M in financing co-led by Supernova Invest, Sofinnova Partners, Andera Partners, Merieux Equity Partners, USVP, and other investors to support U.S. pivotal clinical study and European commercial expansion.*"
}